TD Asset Management’s Rhythm Pharmaceuticals RYTM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.54M | Buy |
56,000
+5,800
| +12% | +$367K | ﹤0.01% | 815 |
|
|
2025
Q1 | $2.66M | Buy |
50,200
+2,400
| +5% | +$127K | ﹤0.01% | 894 |
|
|
2024
Q4 | $2.68M | Buy |
47,800
+16,000
| +50% | +$896K | ﹤0.01% | 927 |
|
|
2024
Q3 | $1.63M | Buy |
31,800
+800
| +3% | +$41.1K | ﹤0.01% | 1094 |
|
|
2024
Q2 | $1.27M | Buy |
31,000
+3,400
| +12% | +$140K | ﹤0.01% | 1118 |
|
|
2024
Q1 | $1.2M | Sell |
27,600
-10,200
| -27% | -$442K | ﹤0.01% | 1142 |
|
|
2023
Q4 | $1.74M | Buy |
+37,800
| New | +$1.74M | ﹤0.01% | 1055 |
|
|
2020
Q1 | – | Sell |
-21,459
| Closed | -$493K | – | 1429 |
|
|
2019
Q4 | $493K | Hold |
21,459
| – | – | ﹤0.01% | 1247 |
|
|
2019
Q3 | $463K | Sell |
21,459
-1,100
| -5% | -$23.7K | ﹤0.01% | 1190 |
|
|
2019
Q2 | $496K | Buy |
22,559
+3,900
| +21% | +$85.7K | ﹤0.01% | 1183 |
|
|
2019
Q1 | $511K | Buy |
18,659
+3,300
| +21% | +$90.4K | ﹤0.01% | 1188 |
|
|
2018
Q4 | $413K | Buy |
15,359
+797
| +5% | +$21.4K | ﹤0.01% | 1259 |
|
|
2018
Q3 | $425K | Buy |
14,562
+2,903
| +25% | +$84.7K | ﹤0.01% | 1327 |
|
|
2018
Q2 | $364K | Buy |
+11,659
| New | +$364K | ﹤0.01% | 1330 |
|